High-salt intake suppressed microRNA-133a expression in Dahl SS rat myocardium

International Journal of Molecular Sciences

Volumn 15, Issue 6, 2014, Pages 10794-10805

  Guo, Tong Shuai ^a   Zhang, Jie ^b   Mu, Jian Jun ^a   Liu, Fu Qiang ^a   Yuan, Zu Yi ^a   Ren, Ke Yu ^a   Wang, Dan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI AN NO 4 HOSPITAL   (China)

Author keywords

microRNA 133a; Myocardial fibrosis; Salt sensitivity

Indexed keywords

COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; MICRORNA; MICRORNA 133A; UNCLASSIFIED DRUG; MIRN133 MICRORNA, RAT; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GERMFREE ANIMAL; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART MUSCLE FIBROSIS; HISTOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFANT; MORPHOMETRICS; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; SALT INTAKE; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD PRESSURE; DAHL RAT; DOWN REGULATION; DRUG EFFECTS; HEART VENTRICLE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD PRESSURE; COLLAGEN TYPE I; CONNECTIVE TISSUE GROWTH FACTOR; DOWN-REGULATION; HEART VENTRICLES; MICRORNAS; MYOCARDIUM; RATS; RATS, INBRED DAHL; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE;

EID: 84902603148     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150610794     Document Type: Article

References (24)

1. Poteshkina, N.G. Salt consumption. Cardiovascular system as a target organ. Part III. Russ. J. Cardiol. 2012, 6, 84-90.
2. Li, X.-Y.; Cai, X.-L.; Bian, P.-D.; Hu, L.-R. High salt intake and stroke: Meta-analysis of the epidemiologic evidence. CNS Neurosci. Ther. 2012, 18, 691-701.
3. Kimura, G.; Dohi, Y.; Fukuda, M. Salt sensitivity and circadian rhythm of blood pressure: The keys to connect ckd with cardiovasucular events. Hypertens. Res. 2010, 33, 515-520.
4. Young, M.J.; Rickard, A.J. Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis. Mol. Cell. Endocrinol. 2012, 350, 248-255.
5. Bartel, D.P. Micrornas: Target recognition and regulatory functions. Cell 2009, 136, 215-233.
6. Liu, N.; Bezprozvannaya, S.; Williams, A.H.; Qi, X.; Richardson, J.A.; Bassel-Duby, R.; Olson, E.N. MicroRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 2008, 22, 3242-3254.
7. + channel expression contributing to QT prolongation in diabetic hearts. J. Biol. Chem. 2011, 286, 28656.
8. Xu, C.; Lu, Y.; Pan, Z.; Chu, W.; Luo, X.; Lin, H.; Xiao, J.; Shan, H.; Wang, Z.; Yang, B. The muscle-specific micrornas miR-1 and miR-133 produce opposing effects on apoptosis by targeting Hsp60, Hsp70 and caspase-9 in cardiomyocytes. J. Cell Sci. 2007, 120, 3045-3052.
9. Torella, D.; Iaconetti, C.; Catalucci, D.; Ellison, G.M.; Leone, A.; Waring, C.D.; Bochicchio, A.; Vicinanza, C.; Aquila, I.; Curcio, A.; et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ. Res. 2011, 109, 880-893.
10. Care, A.; Catalucci, D.; Felicetti, F.; Bonci, D.; Addario, A.; Gallo, P.; Bang, M.L.; Segnalini, P.; Gu, Y.; Dalton, N.D.; et al. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 2007, 13, 613-618.
11. Shan, H.; Zhang, Y.; Lu, Y.; Pan, Z.; Cai, B.; Wang, N.; Li, X.; Feng, T.; Hong, Y.; Yang, B. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc. Res. 2009, 83, 465-472.
12. Duisters, R.F.; Tijsen, A.J.; Schroen, B.; Leenders, J.J.; Lentink, V.; van der Made, I.; Herias, V.; van Leeuwen, R.E.; Schellings, M.W.; Barenbrug, P.; et al. miR-133 and miR-30 regulate connective tissue growth factor: Implications for a role of micrornas in myocardial matrix remodeling. Circ. Res. 2009, 104, 170-178.
13. Castoldi, G.; di Gioia, C.R.T.; Bombardi, C.; Catalucci, D.; Corradi, B.; Gualazzi, M.G.; Leopizzi, M.; Mancini, M.; Zerbini, G.; Condorelli, G.; et al. mir-133a regulates collagen 1A1: Potential role of mir-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J. Cell. Physiol. 2012, 227, 850-856.
14. Huang, B.S.; Leenen, F.H.H. Both brain angiotensin II and "ouabain" contribute to sympathoexcitation and hypertension in dahl s rats on high salt intake. Hypertension 1998, 32, 1028-1033.
15. Heggermont, W.A.; Heymans, S. MicroRNAs are involved in end-organ damage during hypertension. Hypertension 2012, 60, 1088-1093.
16. Elia, L.; Contu, R.; Quintavalle, M.; Varrone, F.; Chimenti, C.; Russo, M.A.; Cimino, V.; de Marinis, L.; Frustaci, A.; Catalucci, D.; et al. Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 2009, 120, 2377-2385.
17. Ikeda, S.; He, A.; Kong, S.W.; Lu, J.; Bejar, R.; Bodyak, N.; Lee, K.-H.; Ma, Q.; Kang, P.M.; Golub, T.R.; et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and MEF2A genes. Mol. Cell. Biol. 2009, 29, 2193-2204.
18. Kumarswamy, R.; Lyon, A.R.; Volkmann, I.; Mills, A.M.; Bretthauer, J.; Pahuja, A.; Geers-Knoerr, C.; Kraft, T.; Hajjar, R.J.; Macleod, K.T.; et al. SERCA2A gene therapy restores microRNA-1 expression in heart failure via an Akt/FOXO3A-dependent pathway. Eur. Heart J. 2012, 33, 1067-1075.
19. Kong, P.; Christia, P.; Frangogiannis, N.G. The pathogenesis of cardiac fibrosis. Cell. Mol. Life Sci. 2014, 71, 549-574.
20. Chen, M.M.; Lam, A.; Abraham, J.A.; Schreiner, G.F.; Joly, A.H. CTGF expression is induced by TGF-β in cardiac fibroblasts and cardiac myocytes: A potential role in heart fibrosis. J. Mol. Cell. Cardiol. 2000, 32, 1805-1819.
21. Varagic, J.; Ahmad, S.; Voncannon, J.L.; Moniwa, N.; Simington, S.W., Jr.; Brosnihan, B.K.; Gallagher, P.E.; Habibi, J.; Sowers, J.R.; Ferrario, C.M. Nebivolol reduces cardiac angiotensin II, associated oxidative stress and fibrosis but not arterial pressure in salt-loaded spontaneously hypertensive rats. J. Hypertens. 2012, 30, 1766-1774.
22. Varagic, J.; Frohlich, E.D.; Susic, D.; Ahn, J.; Matavelli, L.; Lopez, B.; Diez, J. AT1 receptor antagonism attenuates target organ effects of salt excess in shrs without affecting pressure. Am. J. Physiol. Heart Circ. Physiol. 2008, 294, H853-H858.
23. Ferreira, D.N.; Katayama, I.A.; Oliveira, I.B.; Rosa, K.T.; Furukawa, L.N.S.; Coelho, M.S.; Casarini, D.E.; Heimann, J.C. Salt-induced cardiac hypertrophy and interstitial fibrosis are due to a blood pressure-independent mechanism in wistar rats. J. Nutr. 2010, 140, 1742-1751.
24. Bayorh, M.A.; Ganafa, A.A.; Emmett, N.; Socci, R.R.; Eatman, D.; Fridie, I.L. Alterations in aldosterone and angiotensin ii levels in salt-induced hypertension. Clin. Exp. Hypertens. 2005, 27, 355-367.